Mn Services Vermogensbeheer B.V. trimmed its position in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 6.0% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 56,200 shares of the semiconductor company's stock after selling 3,600 shares during the period. Mn Services Vermogensbeheer B.V.'s holdings in Synopsys were worth $24,101,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Brighton Jones LLC increased its position in Synopsys by 5.7% in the 4th quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company's stock valued at $447,000 after acquiring an additional 50 shares during the period. Union Bancaire Privee UBP SA bought a new position in shares of Synopsys in the fourth quarter worth $17,162,000. Allspring Global Investments Holdings LLC grew its stake in shares of Synopsys by 1.1% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 54,412 shares of the semiconductor company's stock worth $26,268,000 after purchasing an additional 587 shares in the last quarter. Legacy Capital Wealth Partners LLC increased its holdings in shares of Synopsys by 32.1% during the fourth quarter. Legacy Capital Wealth Partners LLC now owns 794 shares of the semiconductor company's stock valued at $385,000 after purchasing an additional 193 shares during the period. Finally, Principal Securities Inc. raised its stake in shares of Synopsys by 6.0% during the fourth quarter. Principal Securities Inc. now owns 2,277 shares of the semiconductor company's stock valued at $1,105,000 after purchasing an additional 128 shares in the last quarter. Institutional investors own 85.47% of the company's stock.
Analysts Set New Price Targets
SNPS has been the topic of a number of recent analyst reports. Needham & Company LLC restated a "buy" rating and set a $650.00 price target on shares of Synopsys in a research report on Thursday, May 29th. KeyCorp set a $540.00 target price on Synopsys in a report on Tuesday, June 3rd. Piper Sandler reaffirmed an "overweight" rating and set a $615.00 price target (down from $653.00) on shares of Synopsys in a research note on Thursday, May 29th. Bank of America lowered their price target on Synopsys from $630.00 to $560.00 and set a "buy" rating on the stock in a research report on Wednesday, April 16th. Finally, Wells Fargo & Company cut their price objective on Synopsys from $540.00 to $520.00 and set an "equal weight" rating for the company in a report on Thursday, February 27th. One research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company's stock. According to data from MarketBeat.com, Synopsys has a consensus rating of "Moderate Buy" and a consensus price target of $607.14.
Check Out Our Latest Report on Synopsys
Synopsys Price Performance
NASDAQ SNPS traded up $0.55 on Monday, hitting $479.41. 1,386,356 shares of the stock were exchanged, compared to its average volume of 1,159,313. The company's 50-day moving average price is $466.31 and its two-hundred day moving average price is $480.91. Synopsys, Inc. has a 52-week low of $365.74 and a 52-week high of $624.80. The company has a market capitalization of $74.39 billion, a price-to-earnings ratio of 33.02, a P/E/G ratio of 3.23 and a beta of 1.11.
Synopsys (NASDAQ:SNPS - Get Free Report) last posted its quarterly earnings results on Wednesday, May 28th. The semiconductor company reported $3.67 earnings per share for the quarter, beating the consensus estimate of $3.40 by $0.27. Synopsys had a return on equity of 20.48% and a net margin of 36.12%. The firm had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.60 billion. During the same period in the previous year, the firm earned $3.00 earnings per share. Synopsys's quarterly revenue was up 10.3% on a year-over-year basis. Equities analysts predict that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.
Insider Buying and Selling
In other Synopsys news, CEO Sassine Ghazi sold 11,366 shares of the business's stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $457.93, for a total value of $5,204,832.38. Following the completion of the sale, the chief executive officer now owns 71,589 shares of the company's stock, valued at $32,782,750.77. The trade was a 13.70% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Shelagh Glaser sold 7,310 shares of the stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $485.72, for a total value of $3,550,613.20. Following the transaction, the chief financial officer now directly owns 15,291 shares in the company, valued at approximately $7,427,144.52. This represents a 32.34% decrease in their position. The disclosure for this sale can be found here. 0.62% of the stock is currently owned by corporate insiders.
Synopsys Company Profile
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
See Also

Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.